长非编码 RNA 在本质性高血压发病机制中的作用

Q3 Medicine
Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi
{"title":"长非编码 RNA 在本质性高血压发病机制中的作用","authors":"Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi","doi":"10.2174/0115743624283095240308072648","DOIUrl":null,"url":null,"abstract":"\n\nHypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The\npathogenesis of hypertension can be influenced by a combination of genetic and environmental\nfactors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs\n(lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These\nlncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and\npost-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and\nangiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the\nprogression of hypertension-related pathological events. Therefore, the abnormal expression of\nlncRNAs has emerged as a significant factor in the understanding of essential hypertension and\nits associated mechanisms. To further our understanding, we conducted a comprehensive review\nfocusing on unraveling the functional roles of lncRNAs in essential hypertension.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"38 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Role of Long Non-Coding RNAs in the Pathogenesis of Essential\\nHypertension\",\"authors\":\"Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi\",\"doi\":\"10.2174/0115743624283095240308072648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nHypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The\\npathogenesis of hypertension can be influenced by a combination of genetic and environmental\\nfactors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs\\n(lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These\\nlncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and\\npost-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and\\nangiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the\\nprogression of hypertension-related pathological events. Therefore, the abnormal expression of\\nlncRNAs has emerged as a significant factor in the understanding of essential hypertension and\\nits associated mechanisms. To further our understanding, we conducted a comprehensive review\\nfocusing on unraveling the functional roles of lncRNAs in essential hypertension.\\n\",\"PeriodicalId\":10868,\"journal\":{\"name\":\"Current Signal Transduction Therapy\",\"volume\":\"38 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Signal Transduction Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115743624283095240308072648\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624283095240308072648","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

高血压是一种以血压升高为特征的疾病,具有很大的医疗风险,尤其是与心血管疾病的发展有关。高血压的发病机制可能受到遗传和环境因素的共同影响。最近的科学研究揭示了长非编码 RNAs(lncRNAs)与多种疾病(包括肺动脉高压和本质高血压)的关系。研究发现,lncRNAs 在转录、转录后和翻译后水平发挥着关键作用。通过靶向内皮细胞增殖、迁移、凋亡和血管生成,lncRNAs 可诱导动脉内皮细胞功能紊乱,导致高血压相关病理事件的进展。因此,lncRNAs 的异常表达已成为了解本质性高血压及其相关机制的一个重要因素。为了进一步加深理解,我们进行了一项综合综述,重点揭示了 lncRNA 在本质性高血压中的功能作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Role of Long Non-Coding RNAs in the Pathogenesis of Essential Hypertension
Hypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The pathogenesis of hypertension can be influenced by a combination of genetic and environmental factors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs (lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These lncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and post-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and angiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the progression of hypertension-related pathological events. Therefore, the abnormal expression of lncRNAs has emerged as a significant factor in the understanding of essential hypertension and its associated mechanisms. To further our understanding, we conducted a comprehensive review focusing on unraveling the functional roles of lncRNAs in essential hypertension.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
18
审稿时长
>12 weeks
期刊介绍: In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信